S. B. Krintel

Prediction of treatment response to adalimumab: a double-blind placebo-controlled study of circulating microRNA in patients with early rheumatoid arthritis

S. B. Krintel, Christian Dehlendorff, Merete Lund Hetland et al. · The Pharmacogenomics Journal · 2015 · 67 citations

Inflammation, Rheumatology, Double-blind Placebo-controlled Study +11

The frequency of anti-infliximab antibodies in patients with rheumatoid arthritis treated in routine care and the associations with adverse drug reactions and treatment failure

S. B. Krintel, Veit Peter Grunert, Merete Lund Hetland et al. · Lara D. Veeken · 2013 · 66 citations

Clinical and radiographic outcome of a treat-to-target strategy using methotrexate and intra-articular glucocorticoids with or without adalimumab induction: a 2-year investigator-initiated, double-blinded, randomised, controlled trial (OPERA)

Kim Hørslev‐Petersen, Merete Lund Hetland, Lykke Midtbøll Ørnbjerg et al. · Annals of the Rheumatic Diseases · 2015 · 46 citations

Predictive value of a multi-biomarker disease activity score for clinical remission and radiographic progression in patients with early rheumatoid arthritis: a post-hoc study of the OPERA trial

CH Brahe, Mikkel Østergaard, JS Johansen et al. · Scandinavian Journal of Rheumatology · 2018 · 25 citations · Full text

Monitoring total-body inflammation and damage in joints and entheses: the first follow-up study of whole-body magnetic resonance imaging in rheumatoid arthritis

MB Axelsen, Iris Eshed, Mikkel Østergaard et al. · Scandinavian Journal of Rheumatology · 2017 · 15 citations · Full text